Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profile.

about

Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review.[New antibacterial agents on the market and in the pipeline].

P2860

Q38646905-F9673EBA-554B-436E-A31B-20DAAA9A16AD Q40948209-17ECD507-2F53-4A86-A37C-B98C7A4371BA

P2860

Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profile.

Item

http://www.wikidata.org/entity/Q38545589

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profile.

@en

type

Item

label

Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profile.

@en

prefLabel

Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profile.

@en

P1476

Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profile

@en

P2093

Donald P Levine

http://www.w3.org/2001/XMLSchema#string

Eunice Ann H Wong

http://www.w3.org/2001/XMLSchema#string

Miriam T Levine

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications

Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones

Resistance to antibiotics targeted to the bacterial cell wall

Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study.

Teicoplanin-induced hypersensitivity syndrome with a preceding vancomycin-induced neutropenia: a case report and literature review.

Human organ/tissue growth algorithms that include obese individuals and black/white population organ weight similarities from autopsy data.

Vancomycin-induced neutropenia associated with fever: similarities between two immune-mediated drug reactions.

Risk of hepatic events in patients treated with vancomycin in clinical studies: a systematic review and meta-analysis.

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.

Clinical pharmacokinetics of teicoplanin.

P304

1265-1278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14787210.2015.1068118

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Karl Evans R Henson

P577

2015-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26165756

http://www.w3.org/2001/XMLSchema#string

Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profile.

about

P2860

P2860

Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profile.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698